Longeveron commenced treatment of first Left Heart Syndrome patient using mesenchymal stem cell therapy Read more
PharmaCyte declares completion of 6-Month Stability Study on Encapsulated Cells for Clinical Trial Read more
Neumentum confirms Type B Meeting with FDA appointing New Chief Medical and Scientific Officers Read more